Optical activity of dimolybdenum complex induced by chiral,chelating diamine ligand; syntheses and structures of [Mo2(O2CCF3)2(S,S-dach)2(CH3CN)2][BF4]2 and [Mo2(O2CCF3)2(R,R-dach)2(CH3CN)2][BF4]2 (dach=1,2-diaminocyclohexane)

The first structurally characterized, quadruply bonded complexes containing chiral diamine ligands, [Mo₂(O₂CCF₃)₂(S,S-dach)₂(CH₃CN)₂][BF₄]₂ (1), and [Mo₂(O₂CCF₃)₂(R,R-dach)₂(CH₃CN)₂][BF₄]₂ (2); (dach=1,2-diaminocyclohexane) were prepared by reactions of [Mo₂(O₂CCF₃)₂(CH₃CN)₆][BF₄]₂ with S,S-dach and R,R-dach, respectively, in CH₃CN. Their UV–Vis and circular dichroism (CD) spectra have been recorded and their structures determined by X-ray crystallography. Crystals of complexes 1 and 2 conform to the space groups P2 with two independent half molecules in the asymmetric unit. The two molecules have a similar structure consisting of a Mo₂ unit bridged by two cis-trifluoroacetate ligands and chelated by two dach ligands. Two acetonitrile molecules are coordinated to the Mo centers along the MoMo bond. The absorption wavelength at 507 nm for both 1 and 2 can be assigned to δ_xy→δ_xy* transitions. The solution CD spectra of these two complexes show two prominent bands at 525 and 385 nm and form mirror images of each other. The solid CD spectra of complexes 1 and 2 show marked red-shift in the absorption energies as compared with those measured in solution. The one-electron static coupling mechanism was invoked to explain the CD spectra for these complexes and the second lowest energy bands were assigned to be δ_xy→δ_x²−y² transitions.     

Synthesis and characterisation of the carboxylate linked osmium clusters [{Os3H(CO)10}2(CO2CH2CO2)], [{Os3H(CO)10}2(CO2C2H4CO2)], [{Os3H(CO)10}2(C4O4)] and [{Os3H(CO)10}2(C4O4){Co2(CO)6}]

Reactions between the activated cluster [Os₃(CO)₁₀(NCMe)₂] and malonic acid, succinic acid and dicarboxylic acetylene, respectively, lead to the formation of the linked cluster complexes [{Os₃H(CO)₁₀}₂(CO₂CH₂CO₂)] (1), [{Os₃H(CO)₁₀}₂(CO₂C₂H₄CO₂)] (2), and [{Os₃H(CO)₁₀}₂(C₄O₄)] (3) in good yield. Cluster 3 was subsequently treated with [Co₂(CO)₈] and this results in the addition of a “Co₂(CO)₆” group giving [{Os₃H(CO)₁₀}₂(C₂O₄){Co₂(CO)₆}] (4). The X-ray crystal structures are reported for 2–4. In each structure the two triangular triosmium units are linked by the carboxylate groups and within each complex the carboxylate groups are chelating and bridge two osmium atoms.     

Synthesis and antioxidant activities of 2-oxo-quinoline-3-carbaldehyde Schiff-base derivatives

A series of 2-oxo-quinoline-3-carbaldehyde Schiff-base derivatives 4a₁–4n₂ were designed and synthesized based on the 2-oxo-quinoline structure core as novel antioxidants. In vitro antioxidant activities of these compounds were evaluated and compared with commercial antioxidants ascorbic acid, BHT and BHA, employing DPPH assay, ABTS⁺ assay, O₂^? assay and OH assay. The results showed that IC₅₀ of most compounds were lower than standard value 10 mg/mL, indicating good antioxidant activities of these compounds. In addition, in vitro antioxidant activities screening revealed that 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activities of compounds 4b₂, 4e₁, 4e₂ and 4g₂, 2,2′-azinobis-(3-ethylbenzthiazoline-6-sulphonate) cation (ABTS⁺) radical scavenging activities of compounds 4a₁, 4e₁, 4e₂, 4f₁, 4f₂, 4g₁, 4g₂, 4h₁, 4h₂, 4k₁, 4k₂, 4n₁ and 4n₂, superoxide anion radical scavenging activities of 4b₁, 4e₁, 4f₂, 4j₁, 4k₁, 4k₂, 4m₁, 4m₂, and 4n₂, and hydroxyl radical scavenging activity of almost all the compounds except 4f₁, 4f₂, 4j₂, 4l₁ and 4l₂ were better than that of the commercial antioxidant butylated hydroxytoluene (BHT).     

Synthesis of novel 7-imino-2-thioxo-3,7-dihydro-2H-thiazolo [4,5-d] pyrimidine derivatives as adenosine A2A receptor antagonists

Novel bicyclic thiazolopyrimidine compounds (15–26) were synthesized to develop adenosine A_2A receptor (A_2AR) antagonist for the treatment of Parkinson’s disease (PD). The binding affinity of the compounds (15–26) with A_2AR was evaluated using radioligand binding assay on isolated membranes from stably transfected HEK293 cells. Selectivity of the compounds towards A_2AR was assessed by comparing their binding affinities with A₁ receptors (A₁R). cAMP concentrations were measured from HEK293 cells treated with compounds (15–26) as compared to NECA (A_2AR agonist). The compound (16) possessed strongest A_2AR binding affinity (K_i value = 0.0038 nM) and selectivity (737-fold) versus A₁R. Decrease in A_2AR-coupled release of endogenous cAMP from HEK293 cells treated with compounds (15–26) is evocative of their potential as A_2AR antagonist.     

Synthesis,biological evaluation and molecular modeling of 2-amino-2-phenylethanol derivatives as novel β2-adrenoceptor agonists

A novel series of 2-amino-2-phenylethanol derivatives were developed as β₂-adrenoceptor agonists. Among them, 2-amino-3-fluoro-5-(2-hydroxy-1-(isopropylamino)ethyl)benzonitrile (compound 2f) exhibited the highest activity (EC₅₀ = 0.25 nM) in stimulating β₂-adrenoceptor-mediated cellular cAMP production with a 763.6-fold selectivity over the β₁-adrenoceptor. The (S)-isomer of 2f was subsequently found to be 8.5-fold more active than the (R)-isomer. Molecular docking was performed to determine the putative binding modes of this new class of β₂-adrenoceptor agonists. Taken together, these data show that compound 2f is a promising lead compound worthy of further study for the development of β₂-adrenoceptor agonists.     

Reactions of CO2 with tetrahydroborato copper(I) complexes in moist solvents: Synthesis and reactions of [(phen)2Cu] [(HO)3B(O2CH)] and (phen)(Ph3P)Cu(O2COH) (phen = 1,10-phenanthroline)

Carbon dioxide reacts with the tetrahydroborato copper(I) complex, (phen)(Ph₃P)Cu(BH₄) (phen = 1,10-phenanthroline) (1) in moist tetrahydrofuran and in the presence of free phen affording the ionic derivative [(phen)₂Cu] [(HO)₃B(O₂CH)] (3). The same complex 3 can be obtained from 1 and aqueous formic acid in the presence of phen; from the new tetrahydroborato copper(I) complex, (phen)₂Cu(BH₄) (2), and aqueous formic acid; and from 2 with CO₂ in moist tetrahydrofuran.The reaction of (phen)(Ph₃P)Cu(BH₄) (1) with CO₂ in moist methanol gives the bicarbonato derivative, (phen)(Ph₃P)Cu(O₂COH) (4). The action of alcohols, ROH, on 3 causes the formation of the ionic formato complex [(phen)₂Cu](O₂CH) (5), the boron atom being eliminated as the alkyl boric ester, (RO)₃B. Complex 3 reacts with an alcoholic triphenylphosphine solution giving the already reported covalent formato derivative, (phen)(Ph₃P)Cu(O₂CH). The reaction of 3 with PhCH₂Br gives the benzyl formic ester HCO₂CH₂Ph. The reactivity of 4 toward neutral ligands such as phen and CyNC has been investigated, the ionic bicarbonato derivatives, [(phen)₂Cu](HCO₃) (8) and [(phen)(CyNC)₂Cu](HCO₃) (9), being obtained respectively.     

Synthesis, spectroscopic and magnetostructural evidence for the formation of Cu(II) complexes of pyridyl-2-carboxylate (2-pca) and quinolyl-2-carboxylate (2-qca) as a result of a novel oxidative P-dealkylation reaction of diethyl 2-pyridylmethylphosphonate (2-pmpe) and diethyl 2-quinolylmethylphosphonate (2-qmpe) ligands

The interaction of diethyl 2-pyridylmethylphosphonate (2-pmpe) ligand with CuX₂ salts unexpectedly leads to the formation of compounds of the formula Cu(2-pca)₂ [X=Cl⁻ (1), CH₃COO⁻ (3)], and Cu(2-pca)Cl [X=Cl⁻ (2)] (2-pca=pyridine-2-carboxylate ion). The diethyl 2-quinolylmethylphosphonate ligand (2-qmpe) reacts with CuX₂ salts to similarly yield compounds of stoichiometry Cu(2-qca)₂ · H₂O (X=ClO₄ ⁻ (4)], and for X=Cl Cu(2-qca)₂ · H₂O (5) and Cu(2-qca)Cl (6), (2-qca=quinoline-2-carboxylate ion). These compounds are products of a novel oxidative P-dealkylation reaction, which takes place on 2-pmpe and 2-qmpe ligands under the used conditions. The compounds were characterized by infrared, ligand field, EPR spectroscopy and magnetic studies. Cu(2-pca)₂ exists in two crystalline forms, a blue form (1) and a violet form (3). For 3 the single-crystal structure was determined. The copper atom is four-coordinated in a square-planar geometry. The stack between related (and hence parallel) pca moieties involves interatomic distances of 3.27 Å. Cu(2-qca)₂ · H₂O also exists in two forms, a green (4) and a blue-green (5). Both these complexes are five coordinated, involve the same CuN₂O₃ chromophore and are examples of the distortion isomers. Variable-temperature magnetic susceptibility measurements (1.9-300 K) have shown that the antiferromagnetic coupling observed is much stronger in 6 than in 1, 3, 4 and 5. For 2 a ferromagnetic exchange occurs.     

Bis(O2S2 macrocycle) complexes of palladium(II)

Two isomeric dibenzo-O₂S₂ macrocycles L¹ and L² have been synthesised and their coordination chemistry towards palladium(II) has been investigated. Two-step approaches via reactions of 1:1-type complexes, [cis-Cl₂LPd] (1a: L = L¹, 1b: L = L²), with different O₂S₂ macrocycle systems (L¹ and L²) have led to the isolation of the following bis(O₂S₂ macrocycle) palladium(II) complexes in the solid state: [Pd(L¹)₂](ClO₄)₂ (2a) and a mixture of [Pd(L¹)₂](ClO₄)₂ (2a) + [Pd(L²)₂](ClO₄)₂ (2b).     

Syntheses and molecular structures of 6-halogeno-pyridin-2-olate complexes with the diruthenium(2+) core

The complexes [Ru₂(CO)₅(μ-FpyO)₂]₂ (1), [Ru₂(CO)₄(μ-ClpyO)₂]₂ (2), and [Ru₂(CO)₄(μ-BrpyO)₂]₂ (3) were prepared from Ru₃(CO)₁₂ and 6-fluoro-2-hydroxypyridine (FpyOH), 6-chloro-2-hydroxypyridine (ClpyOH) and 6-bromo-2-hydroxypyridine (BrpyOH), respectively, in hot toluene. Compounds 1-3 are coordination dimers with a cyclo-RuORuO motif. By carrying out the reaction in hot methanol, the dinuclear complexes [Ru₂(CO)₄(μ-ClpyO)₂(CH₃OH)] (4) and [Ru₂(CO)₄(μ-BrpyO)₂(CH₃OH)] (5), respectively, were obtained. Treatment of 2 and 3 with triphenylphosphane provided the complexes [Ru₂(CO)₄(μ-ClpyO)₂(PPh₃)] (6) and [Ru₂(CO)₄(μ-BrpyO)₂(PPh₃)] (7), respectively. The solid-state structures of complexes 1, 2, 4, 6, and 7 were determined by single crystal X-ray diffraction. In all cases, a head-head coordination of the two 6-halopyridinolate ligands at the core was found. In all chlorine- or bromine-containing complexes, the axial coordination site at the ruthenium atom neighbored by two Cl or Br atoms remains unoccupied due to steric shielding by the halogen atom. In the fluoropyridinolate complex 1, the same coordination site is occupied by a carbonyl ligand.     

Syntheses and characterization of novel sterically demanding amido ligand derivatives and their alkali metal ion complexes, crystal structures of [SiH2Mes2], [NH(SiHMes2)2] and [Na{N(SiHMes2)2}(OEt2)]

Three bulky silanes, [SiH₂Mes₂] (1), [SiHMeMes₂] (2), SiHMes₃ (3), two novel amines, [NH(SiHMes₂)₂] (4), NH₂(SiMeMes₂) (5), and three novel alkali metal ion complexes, [Na{N(SiHMes₂)₂}(OEt₂)] (6), Li{N(SiHMes₂)₂} (7), K{N(SiHMes₂)₂} (8), have been synthesized and characterized by multinuclear NMR and mass spectroscopy. The structures of compounds 1, 4 and 6 have been determined by X-ray crystallography. The spectroscopy and structural results are discussed.     

The tungsten-tungsten triple bond. XV. Synthesis,structure and reactivity of 1,2-W2[CH(SiMe3)2]2(NMe2)4: the remarkable inertness of a sterically-encumbered tungsten-amido complex

Addition of 1,2-W₂Cl₂(NMe₂)₄(W≡W) to a toluene slurry of LiCH(SiMe₃)₂(2 equiv) results in the formation of 1,2-W₂[CH(SiMe₃)₂]₂(NMe₂)₄(W≡W) (I) in 79% isolated yield. Compound I has been characterized by ¹H and ¹³C NMR, IR, elemental analysis and single-crystal X-ray diffraction. The molecule exists exclusively in the gauche conformation in solution and in the solid state with WW = 2.320(1) Å. Compound I is very sterically encumbered as evidenced by: (1) large WWC angles, 110°, at the disyl ligand; (2) skewing of the NC₂ planes of the NMe₂ ligands off the WW vector; (3) anomalously large barriers to WNM₂ bond rotation in solution; (4) the inertness of I towards CO₂ and alcohols. However, compound I reacts with acetic anhydride to form 1,2-W₂[CH(SiMe₃)₂]₂(O₂CMe)₄(W≡W) (II) in 31% isolated yield. Compound II has been characterized by ¹H and ¹³C NMR, IR, and elemental analysis. The mechanistic implications of these studies with regard to alcoholysis and CO₂ insertion reactions of other 1,2-W₂R₂(NMe₂)₄ compounds are discussed. Crystal data for 1,2-W₂[CH(SiMe₃)₂]₂(NMe₂)₄ at −140°C: space group P2₁/n, a = 12.555(3), b = 18.699(5), c = 15.214(4) Å, β = 95.24(1)° and Z = 4.     

Analysis of the main structural trends for biscyclometalated dinuclear rhodium compounds of general formula Rh2(O2CR)2(PC)2 · 2H2O

A new series of biscyclometalated dinuclear rhodium (II) compounds with the general formula Rh₂(O₂CR)₂(PC)₂ · 2H₂O, being PC = (C₆H₄)P(C₆H₅)₂, R = CH₃ (1 · 2H₂O), PC = [(p-CH₃ OC₆H₃)P(p-CH₃ OC₆H₄)₂], R = CF₃ (2 · 2H₂O), PC = (C₆H₄)P[CH(CH₃)₂]₂, R = CH₃ (3 · 2H₂O) and PC = (C₆H₄)P(C₆H₅)₂, R = C₆F₅ (4 · 2H₂O) has been obtained. The crystal structures for these compounds have been determined by X-ray diffraction and the main structural trends, bond lengths, bond angles and torsion angles have been analyzed, and have also been compared with the structural parameters for different analogous complexes described previously in the literature.     

Versatile coordination behaviour of Ph2AsCH2AsPh2 with Ru(II)

Treatment of ‘RuCl₃ · 3H₂O’ with Ph₂AsCH₂AsPh₂ (dpam) in hot EtOH gives either trans-[RuCl₂(dpam-As,As′)(dpam-As)₂] (1), or cis-[RuCl₂(dpam-As,As′)₂] (2), depending on the mole ratio. On exposure to light, solutions of 2 isomerise to trans-[RuCl₂(dpam-As,As′)₂] (3). Treatment of [RuCl₂(PPh₃)₃] with two equivalents of dpam in CH₂Cl₂ gave a mixture of two products, from which trans-[RuCl₂(PPh₃) (dpam-As,As′)(dpam-As)] (4) was isolated by recrystallisation. The crystal structures of 1-4 are reported. Complexes 1-3 in CH₂Cl₂ undergo electrochemical oxidation to Ru(III), and the Ru(III) form of 2 undergoes isomerisation on the voltammetric timescale to the Ru(III) form of 3.     

Novel N-biphenyl-2-ylmethyl 2-methoxyphenylpiperazinylalkanamides as 5-HT7R antagonists for the treatment of depression

5-HT₇ receptor (5-HT₇R) is a promising target for the treatment of depression and neuropathic pain. 5-HT₇R antagonists exhibited antidepressant effects, while the agonists produced strong anti-hyperalgesic effects. In our efforts to discover selective 5-HT₇R antagonists or agonists, N-biphenylylmethyl 2-methoxyphenylpiperazinylalkanamides 1 were designed, synthesized, and biologically evaluated against 5-HT₇R. Among the synthesized compounds, N-2′-chlorobiphenylylmethyl 2-methoxyphenylpiperazinylpentanamide 1–8 showed the best binding affinity with a K_i value of 8.69 nM and it was verified as a novel antagonist according to functional assays. The compound 1–8 was very selective over 5-HT_1DR, 5-HT_2AR, 5-HT₃R, 5-HT_5AR and 5-HT₆R and moderately selective over 5-HT_1AR, 5-HT_1BR and 5-HT_2CR. The novel 5-HT₇R antagonist 1–8 exhibited an antidepressant effect at a dose of 25 mg/kg in the forced swimming test in mice and showed a U-shaped dose–response curve which typically appears in 5-HT₇R antagonists such as SB-269970 and lurasidone.     

β3-Adrenoceptor agonists for the treatment of frequent urination and urinary incontinence: 2-[4-(2-{[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino}ethyl)phenoxy]-2-methylpropionic acid

In a search for novel analogues of β₃-adrenoceptor (AR) agonists relaxing the bladder for treatment of urinary dysfunction, 2-[4-(2-{[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino}ethyl)phenoxy]-2-methylpropionic acids (1a–e), into which a fibrate-like structure had been incorporated, were synthesised. Compound 1a was found to be a selective β₃-AR agonist in functional assays using the ferret detrusor (β₃-AR), rat uterus (β₂-AR), and rat atrium (β₁-AR); β₃: EC₅₀=7.8 nM, β₂: IC₅₀=7,300 nM, β₁: EC₂₀=23,000 nM. The introduction of a chlorine atom or methyl substituent at the ortho-position on the phenyl ring of 1a further improved β₃-AR selectivity. In an in vivo study, 1a lowered intrabladder pressure (ED₅₀=31 μg/kg) in rats, without increasing heart rate, in keeping with the in vitro results. Consequently, it is proposed that 1a and its analogues (1b–e), possess β₃-AR agonistic activity in the absence of undesirable β₁- or β₂-AR mediated actions, and may be useful for clinical treatment and pharmacological studies.     

Design and synthesis of (4E)-4-(4-substitutedbenzylideneamino)-3-substituted-2,3-dihydro-2-thioxothiazole-5-carbonitrile as novel A2A receptor antagonists

Novel 2-thioxothiazole derivatives (6–19) as potential adenosine A_2A receptor (A_2AR) antagonists were synthesized. The strong interaction of the compounds (6–19) with A_2AR in docking study was confirmed by high binding affinity with human A_2AR expressed in HEK293T cells using radioligand-binding assay. The compound 19 demonstrated very high selectivity for A_2AR as compared to standard A_2AR antagonist SCH58261. Decrease in A_2AR-coupled release of endogenous cAMP in treated HEK293T cells demonstrated in vitro A_2AR antagonist potential of the compound 19. Attenuation in haloperidol-induced impairment (catalepsy) in Swiss albino male mice pre-treated with compound 19 is evocative to explore its prospective in therapy of PD.     

Development of fluorinated CB2 receptor agonists for PET studies

A convergent strategy was followed to modify systematically carbazole based CB₂ receptor ligands. The length of the N-(fluoroalkyl) group (n in 7), the length of the alkanamide (m in 7) and the substitution pattern of the phenyl moiety (X and Y in 7) were varied systematically. The highest CB₂ affinity was found for the 2-fluoroethyl substituted carbazole derivative 20a (K_i = 5.8 nM) containing the propionamide and the 2-bromo-4-fluorophenyl moiety. According to docking studies 20a fits nicely into the binding pocket of the CB₂ receptor, but elongation of the fluoroethyl side chain leads to a different binding mode of the ligands. The high CB₂ affinity together with the high selectivity over the CB₂ subtype qualifies the fluoroethyl derivative 20a to be developed as a PET tracer.     

Structural studies on zinc(II) complexes with 2-benzoylpyridine-derived hydrazones

2-Benzoylpyridine-phenylhydrazone (H2BzPh), 2-benzoylpyridine-para-chloro-phenylhydrazone (H2BzpClPh), and 2-benzoylpyridine-para-nitro-phenyl (H2BzpNO₂Ph) hydrazone were obtained and fully characterized, as well as their zinc(II) complexes [Zn(H2BzPh)Cl₂] (1), [Zn(H2BzClPh)Cl₂] (2) and [Zn(H2BzpNO₂Ph)Cl₂] (3). During the syntheses of complex 1 a second product crystallized, which was characterized as [Zn(2BzPh)₂] (1a). Upon re-crystallization in 1:9 DMSO:acetone conversion of 2 into [Zn(H2BzpClPh)Cl₂] · H₂O (2a) and of 3 into [Zn(2BzpNO₂Ph)Cl(DMSO)] (3a) occurred. The crystal structures of 1a, 2a and 3a were determined. In 1a the two nearly perpendicular H2BzPh ligands give rise to a distorted octahedral environment around the metal. The 5-fold coordination around the metal is completed with two chloride ions in 2a and with one chloride and one oxygen atom from DMSO in 3a.     

Novel 8-(furan-2-yl)-3-substituted thiazolo [5,4-e][1,2,4] triazolo[1,5-c] pyrimidine-2(3H)-thione derivatives as potential adenosine A2A receptor antagonists

Novel thiazolotriazolopyrimidine derivatives (23–33) designed as potential adenosine A_2A receptor (A_2AR) antagonists were synthesized. Molecular docking studies revealed that all compounds (23–33) exhibited strong interaction with A_2AR. The strong interaction of the compounds (23–33) with A_2AR in silico was confirmed by their high binding affinity with human A_2AR stably expressed in HEK293 cells using radioligand-binding assay. The compounds 24–26 demonstrated substantial binding affinity and selectivity for A_2AR as compared to SCH58261, a standard A_2AR antagonist. Decrease in A_2AR-coupled release of endogenous cAMP in treated HEK293 cells demonstrated in vitro A_2AR antagonist potential of the compounds 24–26. Attenuation in haloperidol-induced motor impairments (catalepsy and akinesia) in Swiss albino male mice pre-treated with compounds 24–26 further supports their role in the alleviation of PD symptoms.     

Novel imidazoline compounds as partial or full agonists of D2-like dopamine receptors inspired by I2-imidazoline binding sites ligand 2-BFI

Based on the well known biological versatility of the imidazoline nucleus, we prepared the novel derivatives 3a–k inspired by 2-BFI scaffold to assess imidazoline molecules as D₂-like dopamine receptor ligands. Conservative chemical modifications of the lead structure, such as the introduction of an hydroxy group in the aromatic ring alone or associated with N-benzyl substitution, provided partial (3f) or nearly full (3e and 3h) agonists, all endowed with D₂-like potency comparable to that of dopamine.